Piper nigrum

Piper nigrum (Black Pepper): A Comprehensive Reference

1. Identity: Botanical Classification, Names, and Common Forms

Piper nigrum L., commonly known as black pepper, is a globally recognized spice with a long history of traditional medicinal use and a growing body of scientific research supporting its pharmacological potential. Known as the "King of Spices," Piper nigrum belongs to the family Piperaceae.

The name "pepper" is derived from the Sanskrit name of long pepper, pippali, which gave rise to the Greek peperi and the Latin piper. The plant is known by many names across languages, including hu jiao (Chinese), kali mirch (Hindi), pimienta (Spanish), fulful/filfil (Arabic), poivre (French), pepe (Italian), and pfeffer (German). In Ayurveda, the plant is traditionally known as Maricha.

Piper nigrum is a flowering vine native to the tropical regions of South India and parts of Southeast Asia. The plant produces small, round fruits that turn from green to red as they mature. It is a perennial vine that can reach heights of 10 meters or more. It has dark green, heart-shaped leaves and small white flowers. The berries grow in clusters and start off green before ripening into red. Once dried, they shrivel into the black, wrinkled peppercorns familiar worldwide.

Black pepper (peppercorns) and white pepper are both obtained from the small dried berries of the vine Piper nigrum. The differing preparations yield distinct products:

• Black pepper: The whole unripe fruit is picked and then sun-dried, allowing the outer hull to blacken and shrivel.
• White pepper: The fully ripe fruit is soaked to remove the outer hull, leaving the inner seed, which is then dried.
• Green pepper: The unripe fruit preserved by freezing, freeze-drying, or brining.
• Standardized extracts: Black pepper extract (commercially marketed as BioPerine®) is a standardized extract prepared from the dried fruits of Piper nigrum and contains a minimum of 95% piperine.
• Essential oil: Obtained by steam hydrodistillation of dried peppercorns, rich in terpene hydrocarbons.
• Cold-pressed oil: Cold-pressed oil (CPO) from Piper nigrum fruits contains the lignan sesamin (39.78%), the alkaloid piperine (33.79%), the monoterpene hydrocarbons 3-carene (9.53%) and limonene (6.23%), and the sesquiterpene β-caryophyllene (10.67%).

2. Traditional and Historical Use

2.1 Ancient India and Ayurveda

Ancient texts from India, such as the Atharvaveda (c. 1200 BCE), mention pepper as a prized commodity used not only in cooking but also in traditional medicine. At least 3,000 years ago, pepper was used medically in India, according to several records, and played an important role in the traditional Ayurvedic medical system.

Black pepper has been revered in Ayurveda for thousands of years. In Ayurveda, its key use is to stimulate the digestive fire (agni), enhancing appetite and nutrient absorption while reducing bloating and gas. It also has a long history of external use in Ayurveda on inflamed skin when mixed with oil or used as a poultice. Black pepper is used externally in the form of paste and cream since the time of the Charaka Samhita in the 2nd century BC.

Ayurvedic medicine uses Piper nigrum extensively to enhance bioavailability, and approximately two-thirds of all traditional Ayurvedic formulas contain this herb. Traditionally, Ayurvedic practitioners would combine Piper nigrum with ginger (Sunthi) and long pepper (Piper longum) to create "Trikatu" — a potent digestive formula.

Black pepper is used traditionally for the treatment of various diseases including cough, cold, dyspnea, throat diseases, intermittent fever, dysentery, stomachache, worms, and piles. Black pepper is traditionally used in India to reduce the kapha-aggravating effect of sweet fruit juices. It is also used in post-partum care and is included in herbal remedies given to new mothers, added to control vata dosha aggravation that naturally occurs post-delivery.

2.2 Traditional Chinese Medicine

Pepper made it to China, being transported overland from India to Sichuan Province by the second century BCE, according to recorded records. Pepper is mentioned in chronicles of the Han Dynasty (202 BCE–220 CE), written in the fifth century CE, as well as in a Tang Dynasty narrative written four centuries later. Pepper has been used for the treatment of epilepsy since the Tang Dynasty in China.

2.3 Ancient Greece and Rome

Since antiquity, pepper has always been the most important spice in the world. It played a central role in the medicines of ancient India and China, became a critical component of Roman food, and remained central in the cuisine of medieval Europe. Pepper cultivation began thousands of years ago in India, where it was native, and was soon introduced to the major islands of Indonesia by traders. Two species of pepper were domesticated: long pepper (Piper longum) in the northeast of India and black pepper (Piper nigrum) in the southwest.

Pepper has grown in India for thousands of years and was first introduced to the West after the global conquests of Alexander the Great (4th century BC). Pepper was so precious in ancient times that it was used as money to pay taxes, tributes, dowries, and rent — weighed like gold and used as a common medium of exchange. In AD 410, when Rome was captured, 3,000 pounds of pepper were demanded as ransom.

Romans used pepper in their food and the famous Roman cookbook, Apicius' De re coquinaria, featured pepper in the majority of its recipes.

2.4 Medieval Europe and the Spice Trade

Following the fall of Rome, Europe entered the medieval era — a time when black pepper became even more valuable due to its rarity and difficulty of transport. Arab and Venetian merchants dominated the spice trade, bringing pepper from Indian ports to Middle Eastern bazaars, and eventually to European cities like Venice and Genoa. By the 11th and 12th centuries, pepper was often used as a form of currency.

Dreams of pepper's acquisition drove Vasco da Gama (c. 1469–1524) around the Cape of Africa to the Indian Ocean and Christopher Columbus (1451–1506) across the Atlantic Ocean to the New World.

Traditionally, pepper is used for arthritis, bronchitis, gastritis, diarrhea, snakebite, menstrual pain, fever, and bacterial infections.

3. Key Constituents and Active Compounds

3.1 Alkaloids

The major bioactive compound identified in P. nigrum is piperine, although other compounds are also present including piperic acid, piperlonguminine, pellitorine, piperolein B, piperamide, piperettine, and (−)-kusunokinin, which also showed biological potency.

Piperine (chemically, (2E,4E)-1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine) is classified as an amide alkaloid. It exhibits pleiotropic properties including antioxidant, anticancer, anti-inflammatory, antihypertensive, hepatoprotective, neuroprotective, and bioavailability-enhancing and fertility-related activities.

3.2 Essential Oil Constituents

Biologically active alkaloid piperine and the main essential oil constituents, including β-caryophyllene, limonene, sabinene, α-pinene, β-bisabolene, and α-copaene, can serve as new natural sources for use in food, aroma, cosmetics, and pharmaceutical industries.

The three most important constituents of seed essential oil are δ-3-carene (11.49%), limonene (13.35%), and β-caryophyllene (37.42%). Hydrodistilled oil (HDO) analysis revealed 35 compounds mainly composed of monoterpene hydrocarbons (77.28%), such as limonene (26.50%), sabinene (21.36%), and β-pinene (15.53%), and sesquiterpene hydrocarbons (20.59%) represented mainly by β-caryophyllene (19.12%).

3.3 Other Phytochemicals

Phytochemical analyses have described the main chemical constituents of black pepper, including carbohydrates, proteins, calcium, magnesium, potassium, iron, vitamin C, tannins, flavonoids, and carotenoids. Other phytochemicals present are amides, piperidine, pyrrolidines, and trace amounts of safrole.

Major phytomolecules identified in P. nigrum leaf extract include piperettine, curcumin, myristicin, pipernonaline, sesamin, and lupenone.

3.4 β-Caryophyllene: A Distinct Active Component

β-Caryophyllene is a natural bicyclic sesquiterpene hydrocarbon and the most abundant constituent in many plant-derived essential oils, including black pepper. β-Caryophyllene is a plant-derived cannabinoid ligand; it functions as a selective agonist of cannabinoid receptor 2 (CB2). CB2 receptor activation is considered a suitable medicinal approach for the treatment of inflammation-related disorders. The United States Food and Drug Administration considers β-caryophyllene a dietary phytocannabinoid and has included it in the list of "generally regarded as safe" (GRAS) ingredients.

4. Established Mechanisms of Action

4.1 Bioavailability Enhancement (Bioperine Effect)

Piperine has been used as a natural bioenhancer with other drugs to potentiate their therapeutic effects. Its bioenhancer effect has been shown by action on metabolizing enzymes, enhancing drug transport, affecting blood supply to the gastrointestinal tract (GIT), and/or membrane fluidity.

Piperine is a known inhibitor of glucuronidation in the liver and intestine, and may thereby provide a corresponding decrease in the metabolism of curcuminoids. Docking studies show that piperine binds to multiple sites on enzymes including CYP3A4 in cytochrome P450, P-glycoprotein, and UDP-glucuronosyltransferase (UGT). Piperine binds to multiple sites on these enzymes and also intercalates with curcumin, forming a hydrogen-bonded complex.

4.2 Anti-Inflammatory Mechanisms

Piperine suppresses reactive oxygen and nitrogen species (ROS/RNS) production, leading to decreased expression of p-p38, p-JNK, AP-1, iNOS, and COX-2 protein expression. Piperine also suppresses IL-6 and IL-8 expression and PGE2 production.

In vitro anti-inflammatory activity of piperine has been tested on interleukin 1β (IL-1β)-stimulated fibroblast-like synoviocytes derived from patients with rheumatoid arthritis, with investigation of IL-6, matrix metalloproteinase (MMPs), COX-2, and prostaglandin E2 (PGE₂) levels.

4.3 Metabolic and Thermogenic Mechanisms

Using ¹H-NMR-based metabolome analysis, piperine increased the level of intracellular lactate in skeletal muscle cells. Piperine also induced the phosphorylation of AMP-activated protein kinase (AMPK) and its downstream target, acetyl-CoA carboxylase (ACC), while additionally stimulating glucose uptake in an AMPK-dependent manner. Increased lactate level resulted in increased expression of mitochondrial uncoupling protein 1 (UCP1), which regulates energy expenditure, thermogenesis, and fat browning.

Data show that piperine enhances thermogenesis of resting muscle via a perturbation of the SRX/DRX ratio (metabolic states of the motor protein myosin). The metabolic rate is increased by shifting myosin from a low activity state to a higher activity state.

4.4 Neuroprotective Mechanisms

Piperine modulates membrane dynamics and increases absorption-site permeability, crossing the blood-brain barrier (BBB) and showing monoamine oxidase B (MAO-B) inhibitory activity. Piperine (an isomer of chavicine) has a favorable pharmacokinetics profile with a high affinity towards brain tissue (98.4–98.5%) and plasma protein (96.2–97.8%), and a brain distribution volume of 36.32 ± 1.40 mL/g.

5. Scientific Evidence by Area of Use

5.1 Bioavailability Enhancement

This is the area where piperine has its most extensively documented human clinical evidence.

Piperine has been shown to increase the bioavailability of curcumin by up to 154% in rats and up to 2,000% in a human study (Shoba et al., 1998). However, the evidence base is narrow: there is a lack of further studies providing direct evidence of piperine enhancing the bioavailability of curcumin in humans. Mimica et al. (2022) recently reviewed clinical studies on curcumin, and although piperine was used in a substantial number of them, there was no comparison of its effect on bioavailability. Most studies rely on the findings of Shoba et al. (1998).

There are several examples of piperine being used to aid the bioavailability of other compounds in humans and rodents. The maximum increase in bioavailability observed was approximately 2-fold (Bano et al., 1991; Di et al., 2015; Lambert et al., 2004).

In the context of drug pharmacokinetics: in 12 healthy subjects, a single dose of carbamazepine 200 mg was given before and after administration of piperine 20 mg/day for 10 days. Carbamazepine area under the curve (AUC) increased by 48% after administration of piperine. In another study, 12 healthy subjects took a single 120-mg dose of fexofenadine before and after administration of piperine 20 mg/day for 10 days. With piperine pretreatment, fexofenadine AUC increased by 68%, though the fexofenadine half-life was not significantly affected.

Evidence strength: Moderate for the mechanism of enzyme and transporter inhibition in humans; limited and heavily reliant on a small number of clinical trials for most specific compound pairs.

5.2 Anti-Inflammatory and Antioxidant Effects

In vitro and in vivo data have provided deep insight into the mechanisms of piperine action, which are related to its antioxidant and anti-inflammatory efficacy, together with its ability to interfere with several molecular signaling pathways.

A 2026 systematic review of randomized controlled trials (RCTs) investigated combined curcumin–piperine supplementation: in a variety of clinical populations, curcumin-piperine supplementation consistently demonstrates anti-inflammatory, antioxidant, metabolic, and cardioprotective effects, with a good safety profile. The convergence of anti-inflammatory, antioxidant, metabolic, and cardioprotective effects observed across diverse RCTs spanning metabolic, cardiovascular, inflammatory, and infectious conditions supports a pleiotropic, systems-level mechanism. This body of evidence indicates that curcumin–piperine modulates interconnected inflammatory, oxidative, and metabolic pathways that are central to the pathophysiology of chronic non-communicable diseases.

A comprehensive review of curcumin-piperine co-supplementation showed beneficial effects in improving glycemic indices, lipid profile and antioxidant status in diabetes, improving the inflammatory status caused by obesity and metabolic syndrome, reducing oxidative stress and depression in chronic stress and neurological disorders, and also improving chronic respiratory diseases, asthma, and COVID-19.

Evidence strength: Most evidence is from in vitro and animal models; human clinical trials, where they exist, have largely examined piperine as an adjunct to curcumin rather than as a sole intervention. Piperine's independent anti-inflammatory effects in humans remain under-characterized.

5.3 Anticancer Potential

Reviews highlight the potential of Piper nigrum extract as a complementary anticancer agent. The plant contains bioactive compounds such as piperine, which have demonstrated significant anticancer activities including cell cycle arrest, apoptosis induction, and inhibition of tumor growth and metastasis. Recent findings from in vitro, in vivo, and clinical studies emphasize the capacity to enhance the efficacy of conventional chemotherapeutic agents while mitigating their side effects.

Piperine's antitumor potential, demonstrated through its apoptotic effect on many cancer types, should be further investigated, especially in the form of human clinical trials, since such data do not exist.

In an animal model study on mammary tumor prevention: treatment with a low-piperine P. nigrum extract (PFPE-CH) at 100 mg/kg body weight for 101 days induced oxidative stress and increased the immune response by altering the levels of cancer-associated cytokines (IL-4, IL-6, and IFN-γ), leading to a reduction in tumor incidence of up to 71.4% without any adverse effects.

Evidence strength: Predominantly in vitro and in vivo (animal model) evidence. Most pharmacological studies were conducted in vitro (n = 60), while only 21 were in vivo and 1 was a clinical trial. Robust human clinical trials in oncology are lacking.

5.4 Metabolic Health and Obesity

Studies comparing the actions of black pepper and piperine on adiposity suppression in mice fed with a high-carbohydrate, high-fat diet found that black pepper suppressed body fat accumulation mainly through the action of piperine. Several animal studies showed that piperine may have anti-obesity, lipid-lowering, and glucose-lowering properties.

Screening of compounds for metabolic rate enhancement identified piperine. Piperine increased the metabolic rate of resting muscle fibers. However, piperine does not have the properties required to be a pharmaceutical in humans, but it would make a good lead compound for finding compounds that do.

Evidence strength: Predominantly preclinical (animal and cell-based). Human clinical data specifically on piperine alone for metabolic outcomes are very limited.

5.5 Neuroprotection and Cognitive Function

Using human neuroblastoma SH-SY5Y cells, P. nigrum extracts protected cells from oxidative damage by reducing ROS production and maintaining mitochondrial membrane integrity, reflecting the antioxidant potential of the extracts.

In sleep-deprived mouse models, P. nigrum extract was found to potentially alleviate brain damage caused by oxidative stress and improve cognitive function by enhancing the activities of GSH, SOD, and CAT in the hippocampus. The extract also reduced serum levels of inflammatory factors.

Data from rat models suggest that anxiolytic and antidepressant responses within elevated plus-maze and forced swimming tests, and increase of antioxidant defence, along with decreased lipid peroxidation and protein oxidation, could be related to neuroprotection against Aβ (1–42)-induced neuronal oxidative stress by methanolic extract of P. nigrum fruits.

Piperine has been reported to exert neuroprotective effects in combination with quercetin as a bioenhancer, improving neurotransmitter levels for GABA, 5-HT, DA, and Glu.

Evidence strength: Primarily cell-based and animal model data. No robust human clinical trials specifically on black pepper or isolated piperine for cognitive or neuroprotective endpoints have been identified.

5.6 Gastrointestinal Effects

Piperine has the ability to alter gastrointestinal disorders, drug-metabolizing enzymes, and bioavailability of several drugs. Stimulation of digestive enzyme secretion and increased gastrointestinal motility have been described in preclinical models. Traditional use for dysentery, stomachache, worms, and indigestion is documented across multiple ancient medical systems.

Evidence strength: Traditional use is well-documented; modern clinical evidence specific to gastrointestinal endpoints remains limited.

5.7 Antimicrobial Activity

P. nigrum exhibits a broad spectrum of antimicrobial activity because of the presence of bioactive compounds, including alkaloids, phenols, and terpenoids, which have been identified as major contributors to its antimicrobial efficacy.

Leaf extract exhibited anti-bacterial activity with higher activity against Gram-positive bacteria, particularly Staphylococcus aureus. Antibacterial assays of essential oils showed variable activity, with inhibition zones against E. coli measuring 1.5–6.83 mm (depending on plant part), and against S. aureus measuring 8.06–13.00 mm.

Evidence strength: Primarily in vitro laboratory data. No robust human clinical trials on antimicrobial outcomes for black pepper or piperine as standalone interventions have been identified.

5.8 Respiratory Health

P. nigrum has demonstrated anti-asthmatic effects in preclinical models. Traditional use for cough, cold, and respiratory disorders is extensively documented. The curcumin-piperine combination has shown some benefit in RCTs for chronic pulmonary complications and asthma, though the independent contribution of piperine in those studies is difficult to isolate.

Evidence strength: Traditional use is very well-established; modern clinical evidence specific to piperine alone for respiratory outcomes is limited.

6. Body Systems and Health Areas Associated with Piper nigrum

• Gastrointestinal system: Digestive stimulant, carminative, antidiarrheal, antiulcer; enhancement of nutrient absorption.
• Pharmacokinetic/Drug metabolism system: Inhibition of CYP3A4, CYP2C9, and P-glycoprotein, leading to enhanced bioavailability of co-administered drugs and nutraceuticals.
• Inflammatory/Immune system: Modulation of COX-2, NF-κB, IL-6, IL-8, TNF-α, and PGE₂ pathways.
• Nervous system: MAO-B inhibition, BBB penetration, antioxidant protection of neurons, modulation of GABA, serotonin, and dopamine pathways.
• Metabolic/Endocrine system: AMPK activation, UCP1 upregulation, effects on adipogenesis and thermogenesis, insulin sensitivity.
• Respiratory system: Historically used for cough, cold, dyspnea, and asthma.
• Cardiovascular system: Antihypertensive and cardioprotective properties in preclinical studies.
• Antimicrobial system: Activity against gram-positive and gram-negative bacteria and fungi.

7. Dosage Forms and Doses Reported in Studies

For adults (≥18 years), a daily dose of 250–420 mg for the unextracted powder of Piper nigrum fruits and a daily maximum dose of 14 mg for piperine as an isolated substance in food supplement products were established in regulatory guidance.

Doses of 5–10 mg of piperine are given concomitantly with nutritional supplements (such as turmeric and resveratrol) to enhance absorption.

In clinical studies investigating pharmacokinetic interactions, piperine has typically been used in doses of 20 mg/day.

In the study of analgesic and antiarthritic effects: piperine was administered orally to rats at 20 and 100 mg/kg/day for 8 days.

In piperine pharmacokinetics reported in healthy volunteers: after dosing (100 and 200 mg), its C_max (the maximum drug concentration observed in plasma) was reported as 3.77 μg/mL and 6.59 μg/mL, respectively, in healthy volunteers.

The findings with β-carotene and coenzyme Q10 indicate that already bolus doses of 5 mg piperine/day may possibly cause interactions with certain substances or drugs.

The following supplement forms appear in the literature and research settings:

• Whole dried fruit powder (peppercorn): 250–420 mg/day (food supplement regulatory guidance)
• Standardized piperine extract (≥95% piperine): 5–20 mg/day (most commonly studied range)
• Piperine as bioenhancer adjunct: 5–10 mg co-administered with target nutraceutical
• Essential oil: used topically or aromatically; specific therapeutic doses not established in clinical trials

8. Safety Considerations and Drug Interactions

8.1 Drug Interactions: Enzyme and Transporter Inhibition

Clinical studies suggest that piperine (usually in doses of 20 mg/day) can inhibit CYP3A4, CYP2C9, and P-glycoprotein (PGP), resulting in moderate increases in plasma concentrations of affected drugs.

Results of recent reports suggest that piperine may increase plasma concentrations of carbamazepine and diclofenac through inhibition of CYP3A4 and CYP2C9, respectively. The authors of the fexofenadine study propose that piperine inhibits P-glycoprotein (PGP), thus increasing fexofenadine bioavailability. Previous evidence from in vitro and animal studies does suggest that piperine inhibits PGP, but more clinical evidence is needed to determine if piperine interacts with other PGP substrates with a greater risk of toxicity, such as digoxin.

Interactions (increased bioavailability of drugs) in humans were observed with several drugs at bolus doses of 20 mg piperine/day. For one drug (midazolam), increased clinical efficacy was reported with bolus administration of 15 mg piperine/day.

Piperine is a bioavailability enhancer which can increase bioavailability when used in combination with rifampicin, phenytoin sodium, verapamil, and other agents.

8.2 Reproductive and Developmental Concerns (Animal Studies)

Animal studies with higher daily piperine bolus doses than in human interaction studies provide indications of disturbance of spermatogenesis and of maternal reproductive and embryotoxic effects. Although the available human studies rarely reported effects that were regarded as being adverse, their suitability for detailed risk assessment is limited due to an insufficient focus on safety parameters apart from drug interactions.

Due to some negative effects on the liver and on male fertility when given in high doses in animal studies, future studies should focus on finding a safe therapeutic dose for pure piperine.

8.3 Gastrointestinal Irritation

Compared to the use of pepper for food seasoning, piperine used in food supplements is in an isolated, concentrated form and ingested as a bolus. The present reviews focus on the assessment of the possible critical health effects regarding the use of isolated piperine as a single ingredient in food supplements. Gastrointestinal irritation is a recognized adverse effect at higher doses.

8.4 Limitations of the Safety Evidence Base

In human and animal studies with single or short-term bolus application of isolated piperine, interactions with several drugs, in most cases resulting in increased drug bioavailability, were observed. Depending on the drug and the extent of the interaction, such interactions may carry the risk of unintended, deleteriously increased or adverse drug effects.

Challenges to the clinical application of Piper nigrum extracts include variability in phytochemical composition, which is a major concern, as it depends on factors like plant origin, harvesting time, extraction methods, and environmental conditions. This variability complicates standardization and makes it difficult to ensure consistent efficacy and safety in preclinical and clinical studies.

8.5 Overall Evidence Limitations

Minimal investigations have been conducted using animal models, and many of these studies also lacked appropriate experimental settings like doses and control details. Future studies are necessary to understand the mechanism of piperine, black pepper essential oil (BPEO), and bioactive constituents and their effects when used by animal models and humans, with proper experimental procedure.

References

• Jain A et al. (2025). Piper nigrum L.: A Systematic Review of its Botanical Characteristics, Phytochemistry, and Pharmacological Activities. Journal of Natural Remedies, 25(9), 2007–2037.
• Butt MS et al. (2019). A systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applications. PubMed / Phytotherapy Research.
• Salehi B et al. (2021). Phytochemistry and therapeutic potential of black pepper [Piper nigrum (L.)] essential oil and piperine: a review. Clinical Phytoscience.
• ScienceDirect Topics: Piper Nigrum — overview.
• Al-Ishaq RK et al. (2024). Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment. Antioxidants, 13(3), 331.
• UK Committee on Toxicity (COT). Turmeric and Curcumin Supplements — Toxicokinetics.
• Bhardwaj A et al. (2016). Quantum Chemical and Docking Insights into Bioavailability Enhancement of Curcumin by Piperine in Pepper. Journal of Physical Chemistry A.
• Pharmacy Times. Piperine Drug Interactions.
• Würtele G et al. (2021). Safety Aspects of the Use of Isolated Piperine Ingested as a Bolus. PMC / Molecular Nutrition & Food Research.
• Murata RM et al. (2020). Overview of the Anticancer Potential of the "King of Spices" Piper nigrum and Its Main Constituent Piperine. PMC / Molecules.
• Mad-adam N et al. (2025). Harnessing the anticancer potential of Piper nigrum: a synergistic approach to chemotherapy enhancement and reduced side effects. PMC.
• Bang JS et al. (2009). Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. PMC / Arthritis Research & Therapy.
• Gorgani L et al. (2022). Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials. PMC / Beni-Suef University Journal of Basic and Applied Sciences.
• Frontiers in Nutrition (2026). Curcumin-piperine supplementation modulates inflammation, oxidative stress, and cardiometabolic risk: a systematic review of randomized controlled trials.
• Ahmadi F et al. (2022). Curcumin-piperine co-supplementation and human health: a comprehensive review of preclinical and clinical studies. Phytotherapy Research.
• Meghwal M & Goswami TK (2019). Piperine — A Major Principle of Black Pepper: A Review of Its Bioactivity and Studies. Applied Sciences, 9(20), 4270.
• Kang S et al. (2017). Piperine regulates UCP1 through the AMPK pathway by generating intracellular lactate production in muscle cells. Scientific Reports.
• Cooke R et al. (2016). Piperine's mitigation of obesity and diabetes can be explained by its up-regulation of the metabolic rate of resting muscle. PNAS.
• Dey A et al. (2023). Black Pepper (Piper nigrum) Alleviates Oxidative Stress, Exerts Potential Anti-Glycation and Anti-AChE Activity. PMC.
• Baranauskaite J et al. (2021). Neuroprotective Effects of Black Pepper Cold-Pressed Oil on Scopolamine-Induced Oxidative Stress and Memory Impairment in Rats. PMC.
• Mao QQ et al. (2023). Neuroprotective Effects of Black Pepper and Its Bioactive Compounds in Age-Related Neurological Disorders. PMC.
• MDPI / PMC (2025). The Extract of Piper nigrum Improves the Cognitive Impairment and Mood in Sleep-Deprived Mice Through the JAK1/STAT3 Signalling Pathway.
• Rinwa P & Kumar A (2015). Anxiolytic and antidepressant profile of the methanolic extract of Piper nigrum fruits in beta-amyloid (1–42) rat model of Alzheimer's disease. PMC.
• PMC (2025). Essential Oils From Different Parts of Piper nigrum L.: Chemical Composition, Antibacterial, and Antioxidant Activities.
• Mad-adam N et al. (2023). Piper nigrum Extract: Dietary Supplement for Reducing Mammary Tumor Incidence and Chemotherapy-Induced Toxicity. PMC / Foods.
• World History Encyclopedia. Pepper.
• McCormick Science Institute. Black Pepper.
• Herbal Reality. Black Pepper (Piper nigrum): Benefits, Uses & Dosage.
• Abd Halim et al. (2025). Piper nigrum as a Source of Antimicrobial Agents: Bioactive Constituents, Mechanistic Insights, and Synthetic Derivatives. ChemistrySelect.